首页> 外文期刊>Journal of consumer protection and food safety >Kava bought in the Internet - Stimulants, Dietary Supplements, Medicine or Cancer Risk?
【24h】

Kava bought in the Internet - Stimulants, Dietary Supplements, Medicine or Cancer Risk?

机译:Kava在互联网上购买-兴奋剂,膳食补充剂,药物或癌症风险?

获取原文
获取原文并翻译 | 示例
           

摘要

The inhabitants of the South Pacific islands traditionally use the kava plant (Piper methysticum) for producing a beverage with relaxing effects. Since the 1990s, Kava is also popular in the western countries and has been used in Europe and America in tablet and capsule form to treat anxiety disorders. Kava exhibits anxiolytic and sleep-enhancing effects in humans. Research in experimental animals has proven sedative, anticonvulsant and central muscle relaxant effects, which may be caused by kavalactones as major constituents of kava. In 2002, kava has lost its authorisation as a medicinal product because of considerable side effects, particularly damage to the liver. Test purchases and analyses show that medicinal products containing pharmacologically active concentrations of kavalactones are still sold over the internet to the German consumer as food supplements. The natural origin is highlighted as an advantage over synthetic tranquilizers. A high priority to control the internet market with kava products may arise from its recent evaluation as "possibly carcinogenic to humans" (Group 2B) by the WHO International Agency for Research on Cancer (IARC).
机译:传统上,南太平洋岛屿的居民使用卡瓦植物(Piper methysticum)生产具有放松效果的饮​​料。自1990年代以来,卡瓦(Kava)在西方国家也很流行,在欧洲和美国以片剂和胶囊剂形式用于治疗焦虑症。卡瓦在人类中表现出抗焦虑和增强睡眠的作用。在实验动物中的研究已证明具有镇静,抗惊厥和中枢肌肉松弛作用,这可能是由卡瓦内酯作为卡瓦的主要成分引起的。 2002年,由于相当大的副作用,特别是对肝脏的损害,卡瓦已经失去了其作为药品的授权。购买测试和分析表明,含有药理学活性浓度的kavalactones的医药产品仍通过互联网出售给德国消费者作为食品补充剂。天然来源被强调为优于合成镇静剂的优势。世界卫生组织国际癌症研究机构(IARC)对卡瓦产品控制互联网市场的高度重视可能来自其最近的评估“可能对人类致癌”(2B组)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号